Healthcare -
Biotechnology - NASDAQ - US
$ 5.835
4.47 %
$ 269 M
Market Cap
-1.71
P/E
URGN - OPERATING INCOME
Operating Income URGN - UroGen Pharma Ltd.
-96.8 M
LAST VALUE
-10.66%
2 YEAR CAGR
2.44%
5 YEAR CAGR
-36.31%
10 YEAR CAGR